Stocksigma LogoStocksigma Logo

Avience Biomedicals Reports Strong H1 FY27 Financial Results

Avience Biomedicals reported consolidated revenue from operations of Rs 3,112.86 lakhs for the half-year ended 30th Sep'26, up 16.07% YoY from Rs 2,681.93

Avience Biomedicals Reports Strong H1 FY27 Financial Results

Avience Biomedicals Ltd 路 Outcome 路 11 Nov 2026, 2:51 am

Avience Biomedicals Reports Strong H1 FY27 Financial Results Avience Biomedicals reported consolidated revenue from operations of Rs 3,112.86 lakhs for the half-year ended 30th Sep'26, up 16.07% YoY from Rs 2,681.93 lakhs in the half-year ended 30th Sep'25. Net profit rose 21.99% YoY to Rs 553.62 lakhs compared to Rs 453.78 lakhs, while basic and diluted EPS stood at Rs 10.10 against Rs 11.26. On a standalone basis, revenue reached Rs 2,368.69 lakhs with a net profit of Rs 466.64 lakhs. The company also utilised Rs 2,523.90 lakhs of its Rs 3,023.90 lakh IPO proceeds.

Original exchange filing (PDF)

More announcements from Avience Biomedicals Ltd

All Avience Biomedicals Ltd announcements